Digestive System Neuroendocrine Neoplasm
📧 Sign up to get email alerts when something new happens for Digestive System Neuroendocrine Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors [Phase 2]
This Phase 2 trial investigates the combination of lenvatinib and everolimus in patients with advanced, unresectable carcinoid tumors and re…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors. [Phase 1]
A Phase 1 trial is evaluating the combination of external radiation and peptide receptor radionuclide therapy for large unresectable gastroi…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors [Phase 2]
This Phase 2 trial evaluates Abemaciclib in patients with advanced, unresectable, and/or metastatic digestive system neuroendocrine tumors; …
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors [Phase 1]
Phase 1 trial evaluating the addition of Triapine to Lutetium-177 dotatate radioligand therapy for metastatic neuroendocrine tumors; results…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 3]
Phase 3 trial evaluating cabozantinib in advanced pancreatic neuroendocrine and carcinoid tumors; ACTIVE_NOT_RECRUITING with results posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin [Phase 2]
Phase 2 clinical trial update evaluating ribociclib in advanced neuroendocrine tumors of foregut origin has been completed with posted resul…